Correlation between anti-PD-L1 tumor concentrations and tumor-specific and nonspecific biomarkers in a melanoma mouse model

Blockade of PD-L1 with specific monoclonal antibodies (anti-PD-L1) represents a therapeutic strategy to increase the capability of the immune system to modulate the tumor immune-resistance. The relationship between anti-PD-L1 tumor exposition and anti-tumor effect represents a challenge that has bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Contreras, Ana M., Merino, María, Vasquez, Marcos, Trocóniz, Iñaki F., Berraondo, Pedro, Garrido, María J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363557/
https://www.ncbi.nlm.nih.gov/pubmed/27764774
http://dx.doi.org/10.18632/oncotarget.12727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363557/
https://www.ncbi.nlm.nih.gov/pubmed/27764774
http://dx.doi.org/10.18632/oncotarget.12727

Ejemplares similares